190 related articles for article (PubMed ID: 12903600)
1. [Predictive factors for malignancy in Hürthle-cell thyroid neoplasia. Effect of surgical treatment].
Pisanu A; Aste L; Piu S; Cois A; Uccheddu A
Tumori; 2003; 89(4 Suppl):223-5. PubMed ID: 12903600
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting malignancy of Hürthle cell tumors of the thyroid: influence on surgical treatment.
Pisanu A; Sias L; Uccheddu A
World J Surg; 2004 Aug; 28(8):761-5. PubMed ID: 15457355
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of Hurthle cell tumors of the thyroid.
Chao TC; Lin JD; Chen MF
World J Surg; 2005 Feb; 29(2):164-8. PubMed ID: 15650796
[TBL] [Abstract][Full Text] [Related]
4. Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy?
Chen H; Nicol TL; Zeiger MA; Dooley WC; Ladenson PW; Cooper DS; Ringel M; Parkerson S; Allo M; Udelsman R
Ann Surg; 1998 Apr; 227(4):542-6. PubMed ID: 9563543
[TBL] [Abstract][Full Text] [Related]
5. Detection of Hurthle cell carcinoma using sestamibi.
Chamnanrabiabkij E; Welch A; Jayapaul MK; Perros P
Thyroid; 2008 May; 18(5):575-6. PubMed ID: 18044993
[No Abstract] [Full Text] [Related]
6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
7. Surgeon-performed ultrasound predictors of malignancy in patients with Hürthle cell neoplasms of the thyroid.
Parikh PP; Allan BJ; Lew JI
J Surg Res; 2013 Sep; 184(1):247-52. PubMed ID: 23535112
[TBL] [Abstract][Full Text] [Related]
8. [Hürthle cell adenoma: false positive in (99m)Tc-sestamibi hyperparathyroidism study].
Morera Ocón FJ; Sales Maicas MA; García-Granero Ximénez M; Agramunt Lerma M
Med Clin (Barc); 2009 Jun; 133(3):118-9. PubMed ID: 19539827
[No Abstract] [Full Text] [Related]
9. [Methodology for evaluation of malignancy screening in surgical thyroid gland disease].
Rubio V; Tamarit JM; Baviera N; Fernández S; Estrems P; Seijas T; López C; Dalmau J
Acta Otorrinolaringol Esp; 2009; 60(6):390-5. PubMed ID: 19850274
[TBL] [Abstract][Full Text] [Related]
10. [Thyroidal oxyphilic tumors].
Sabo R; Zohar Y; Schwartz A; Segal K
Harefuah; 1994 Feb; 126(4):183-6, 240. PubMed ID: 8168757
[TBL] [Abstract][Full Text] [Related]
11. Older age and larger tumor size predict malignancy in hürthle cell neoplasms of the thyroid.
Zhang YW; Greenblatt DY; Repplinger D; Bargren A; Adler JT; Sippel RS; Chen H
Ann Surg Oncol; 2008 Oct; 15(10):2842-6. PubMed ID: 18665423
[TBL] [Abstract][Full Text] [Related]
12. Unilateral lobectomy for Hurthle cell adenoma.
Wasvary H; Czako P; Poulik J; Lucas R
Am Surg; 1998 Aug; 64(8):729-32; discussion 732-3. PubMed ID: 9697901
[TBL] [Abstract][Full Text] [Related]
13. Thyroid Hürthle cell tumors: research of potential markers of malignancy.
Donatini G; Beaulieu A; Castagnet M; Kraimps JL; Levillain P; Fromont G
J Endocrinol Invest; 2016 Feb; 39(2):153-8. PubMed ID: 26188382
[TBL] [Abstract][Full Text] [Related]
14. Identification of Hürthle cell tumor by single-injection, double-phase scintigraphy with technetium-99m-sestamibi.
Vattimo A; Bertelli P; Cintorino M; Burroni L; Volterrani D; Vella A
J Nucl Med; 1995 May; 36(5):778-82. PubMed ID: 7738647
[TBL] [Abstract][Full Text] [Related]
15. Hürthle cell tumor dwelling in hot thyroid nodules: preoperative detection with technetium-99m-MIBI dual-phase scintigraphy.
Vattimo A; Bertelli P; Cintorino M; Burroni L; Volterrani D; Vella A; Lazzi S
J Nucl Med; 1998 May; 39(5):822-5. PubMed ID: 9591583
[TBL] [Abstract][Full Text] [Related]
16. Coexistent parathyroid adenomas and Hurthle cell tumors: failure of full detection by subtraction method.
Hales KF; Rosenberg RJ; Spencer RP
Clin Nucl Med; 1998 Apr; 23(4):205-7. PubMed ID: 9554189
[TBL] [Abstract][Full Text] [Related]
17. Thyrotoxicosis: a rare presenting symptom of Hurthle cell carcinoma of the thyroid.
Wong CP; AuYong TK; Tong CM
Clin Nucl Med; 2003 Oct; 28(10):803-6. PubMed ID: 14508269
[TBL] [Abstract][Full Text] [Related]
18. Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid.
Sippel RS; Elaraj DM; Khanafshar E; Zarnegar R; Kebebew E; Duh QY; Clark OH
World J Surg; 2008 May; 32(5):702-7. PubMed ID: 18224463
[TBL] [Abstract][Full Text] [Related]
19. Fine-needle aspiration biopsies in the management of indeterminate follicular and Hurthle cell thyroid lesions.
Mijović T; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Payne RJ
Otolaryngol Head Neck Surg; 2009 May; 140(5):715-9. PubMed ID: 19393417
[TBL] [Abstract][Full Text] [Related]
20. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
